Manfred Groeppel's most recent trade in Immunic Inc was a trade of 45,000 Stock Option done . Disclosure was reported to the exchange on March 1, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Immunic Inc | Manfred Groeppel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 45,000 | 45,000 | - | - | Stock Option | |
Immunic Inc | Manfred Groeppel | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 14.44 per share. | 20 Jul 2020 | 5,000 | 279,480 (2%) | 0% | 14.4 | 72,201 | Common Stock |
Immunic Inc | Manfred Groeppel | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.62 per share. | 20 Jul 2020 | 650 | 278,830 (2%) | 0% | 15.6 | 10,155 | Common Stock |
Immunic Inc | Manfred Groeppel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 30,000 | 30,000 | - | - | Stock Option |